mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.097 |
0.08 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.2 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.5 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |